Swiss Life Asset Management »

Bicara Therapeutics shares owned by Swiss Life Asset Management

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Swiss Life Asset Management from 13F filings

Historical chart of Swiss Life Asset Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Swiss Life Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Swiss Life Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $979k 8.7k 113.13

More positions owned by Swiss Life Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Verizon Communications (VZ)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Altria (MO)
Pfizer (PFE)
Visa Com Cl A (V)

View all positions for Swiss Life Asset Management

Top funds holding Bicara Therapeutics

RA Capital Management
Vestal Point Capital
Siren
Deep Track Capital
FMR
Henderson Group
T. Rowe Price Investment Management
Red Tree Management
Tpg Gp A
BlackRock
Omega Fund Management
Vanguard Group
Vanguard Capital Management
Citadel Advisors
State Street Corporation

View all funds holding Bicara Therapeutics